Prokidney: Clinical Trials

4 trials sponsored by Prokidney, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 terminated. 4 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 24Completed 3, Terminated 1

Follow Prokidney: new trials by email

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Renal Autologous Cell Therapy (REACT) in Subjects With Type 1 or 2 Diabetes and Chronic Kidney Disease (REGEN-007)
Renal Autologous Cell Therapy (REACT) - Chronic Kidney Diseases, Type 1 Diabetes Mellitus
Phase 2CompletedProkidney532021-07-272026-03-13
A Study of Autologous Renal Autologous Cell Therapy (REACT) in Patients With Diabetic Chronic Kidney Disease
Renal Autologous Cell Therapy (REACT) - Type 2 Diabetes Mellitus, Chronic Kidney Disease
Phase 2CompletedProkidney102018-04-252025-03-24
A Study of Renal Autologous Cell Therapy (REACT) in Type 2 Diabetics With Chronic Kidney Disease
Renal Autologous Cell Therapy (REACT), Renal Biopsy - Type 2 Diabetes Mellitus, Chronic Kidney Disease
Phase 2CompletedProkidney832016-09-012025-08-24
Autologous Neo-Kidney Augment (NKA) in Patients With Type 2 Diabetes and Chronic Kidney Disease (CKD)
Neo-Kidney Augment - Chronic Kidney Disease, Type 2 Diabetes
Phase 2TerminatedProkidney12016-07-012021-04-23

Conditions studied

Diabetes Mellitus, Type 2 (4)  ·  Renal Insufficiency, Chronic (4)  ·  Diabetes Mellitus, Type 1 (1)

Countries

United States (4)

Top investigators

Ashley Johns (1)  ·  Ashley Johns, MSHS (1)  ·  Brian Johnston (1)  ·  Catherine Taylor (1)

Results publications

PMID 35034024, PMID 41481370